2023 VISION Registry Data Report

II. Quality of Life

QOL reported by patients with primary ocular melanoma comparing female versus male respondents. 49 responses

QOL Scores Quality of life (QOL) reported by patients with primary ocular melanoma living in different countries. 49 responses

81

FEMALE (34 responses)

69

AUSTRALIA (1 response)

87

MALE (15 responses)

73

MEXICO (1 response)

83

UNITED STATES (47 responses)

QOL reported by patients with primary ocular melanoma comparing different primary tumor treatments. 49 responses

QOL reported by patients with primary ocular melanoma at different ages. 49 responses 80 AGE RANGE 30–49 years (8 responses) 82 AGE RANGE 50–69 years (31 responses) 85 AGE RANGE 70+ years (10 responses)

79

ENUCLEATION (13 responses)

83

PLAQUE RADIATION (40 responses)

88

PROTON BEAM RADIATION (5 responses)

73

SURGICAL RESECTION (1 response)

QOL SCORE RANGE: 0–108 The higher the score, the better the patient’s reported quality of life.

2023 VISION Registry Data Report

34

Made with FlippingBook Ebook Creator